Sentonix, Inc.

Pharmaceutical company · Arlington, Massachusetts, United States

Sentonix, Inc. is a pharmaceutical company headquartered in Arlington, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Sentonix at a glance

Typepharmaceutical company

HeadquartersArlington, Massachusetts, United States

Earliest incorporation on record2023

SEC CIK2039609

What does Sentonix do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $6.5 million sold (2025).

Frequently asked questions about Sentonix

Where is Sentonix headquartered?

Sentonix, Inc. is headquartered in Arlington, Massachusetts, United States.

What does Sentonix do?

Sentonix, Inc. is a pharmaceutical company.

When was Sentonix founded?

The earliest incorporation on record for Sentonix, Inc. is in 2023, according to public company registers.

Similar companies

KALA BIO, Inc.Arlington, Massachusetts, United States
Sojournix, Inc.Arlington, Massachusetts, United States
Enumeral Biomedical Holdings, Inc.Arlington, Massachusetts, United States
Revere Pharmaceuticals Inc.Arlington, Massachusetts, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences